微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 24.94% | -29.05% | 0.5% | 116/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 24.82% | -34.24% | -6.56% | 115/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 26.56% | -27.33% | -18.57% | 114/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 32.62% | -13.53% | -7.21% | 106/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 35.16% | -8.89% | -6.86% | 102/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 37.75% | 0.77% | 3.26% | 93/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 36.55% | -13.12% | -3.1% | 102/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 37.72% | -9.29% | -2.24% | 99/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 38.59% | -5.26% | 3.02% | 101/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 37.46% | -6.38% | -10.97% | 96/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 42.07% | -4.62% | 1.16% | 95/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 41.59% | -6.2% | 2.11% | 92/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 40.73% | -7.88% | 1.8% | 94/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 40.01% | -16.08% | -9.3% | 90/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 44.11% | -3.73% | -0.5% | 87/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 44.34% | -7.57% | 0.28% | 82/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 44.21% | -8.53% | -7.26% | 85/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 47.68% | -7.32% | 4.05% | 76/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 45.82% | -9.03% | -4.47% | 93/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 47.97% | -11.49% | -0.77% | 77/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 48.34% | -13.66% | -6.03% | 83/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 51.44% | -11.66% | 2.12% | 70/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 50.37% | 7.46% | -7.05% | 87/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 54.19% | 19.39% | -3.2% | 61/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 55.99% | 20.28% | -3.85% | 71/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 58.23% | 43.99% | 24.22% | 42/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 46.87% | 7.5% | 3.27% | 78/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 45.39% | 2.09% | -2.48% | 40/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 46.55% | 4.98% | 15.11% | 48/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 40.44% | -7.66% | -7.26% | 38/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 43.6% | 5.46% | -1.93% | 75/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 44.46% | 1.84% | 0.27% | 30/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 44.34% | -2.54% | 1.25% | 37/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 43.79% | -5.99% | 5.92% | 30/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 41.34% | 4.8% | -5.3% | 74/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 43.66% | 7.98% | -4.04% | 29/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 45.5% | 15.3% | -2.33% | 34/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 46.58% | 16.4% | 18.08% | 26/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 39.45% | 18.56% | -2.43% | 61/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 40.43% | 15.35% | 2.47% | 27/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 39.46% | 16.32% | -1.39% | 35/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 40.02% | 35.3% | 20.26% | 22/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |